Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reno Debets

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Journal for Immunotherapy of Cancer|June 24, 2026
Blood-based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage NSCLC: the prospective IOpener studyKarlijn de Joode, Harry J Groen, Michel van den Heuvel, et al.
Nature Communications|February 14, 2024
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancerMaud Rijnders, J Alberto Nakauma-González, Debbie G J Robbrecht, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancerDaan P Hurkmans, Els M E Verdegaal, Sabrina A Hogan, et al.
Nature Communications|September 27, 2016
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltrationMarcel Smid, F Germán Rodríguez-González, Anieta M Sieuwerts, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Journal for Immunotherapy of Cancer|June 24, 2026
Blood-based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage NSCLC: the prospective IOpener studyKarlijn de Joode, Harry J Groen, Michel van den Heuvel, et al.
Nature Communications|February 14, 2024
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancerMaud Rijnders, J Alberto Nakauma-González, Debbie G J Robbrecht, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancerDaan P Hurkmans, Els M E Verdegaal, Sabrina A Hogan, et al.
Nature Communications|September 27, 2016
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltrationMarcel Smid, F Germán Rodríguez-González, Anieta M Sieuwerts, et al.
Pageof 14